On February 16, 2024, Steve Williamson informed Outset Medical, Inc. of his decision to depart from the Company and his role as Chief Commercial Officer, effective March 1, 2024, to become the CEO of another publicly traded medical device company. Mr. Williamson?s departure is not due to any dispute or disagreement with the Company or its management.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.5 USD | +12.90% | -7.65% | -35.30% |
13/05 | Morgan Stanley Lowers Price Target on Outset Medical to $4.50 From $5.50, Keeps Equalweight Rating | MT |
08/05 | Transcript : Outset Medical, Inc., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.30% | 18Cr | |
+12.06% | 23TCr | |
+12.07% | 19TCr | |
+13.88% | 14TCr | |
+27.12% | 11TCr | |
+0.53% | 6.41TCr | |
+13.39% | 5.21TCr | |
+6.74% | 5.19TCr | |
+8.81% | 4.43TCr | |
+4.14% | 3.68TCr |
- Stock Market
- Equities
- OM Stock
- News Outset Medical, Inc.
- Outset Medical, Inc. Announces Departure of Steve Williamson as Chief Commercial Officer, Effective March 1, 2024